VertiFlex® is a privately held medical device company dedicated to the advancement of minimally invasive and motion preserving technologies for disorders of the spine. Founded in 2005 and headquartered in San Clemente, CA, VertiFlex currently markets products globally in addition to conducting a pivotal human IDE trial for a next generation interspinous spacer. To date, VertiFlex has raised approximately $62 million in venture capital. Current investors include Aberdare Ventures, Alta Partners, Morgenthaler, and New Enterprise Associates.